Favipiravir
Favipiravir is a pyrazinecarboxamide derivative and a potent inhibitor of viral RNA-dependent RNA polymerase (RdRp), widely studied for its efficacy against influenza and other RNA viruses.
Description
Comprehensive Product Overview
In the field of infectious disease pharmacology, the ability to induce chain termination during viral replication is a major advantage. Favipiravir is specifically selected because it selectively inhibits the RNA-dependent RNA polymerase (RdRp) of numerous RNA viruses. For instance, it is used to investigate the suppression of Arena-, Flavi-, and Bunyaviridae families. Consequently, it facilitates the development of high-efficacy oral antiviral therapies with higher efficiency. As a result, Zyntex ensures that our high-purity API is produced with a focus on isomer stability and minimal residual impurities to ensure reliable research outcomes.
[Image of the molecular structure of Favipiravir]
Moreover, the research-grade Favipiravir provided by Zyntex is a vital component in the study of viral “lethal mutagenesis.” This application allows for the creation of advanced mutagenic drift profiles, undoubtedly pushing the boundaries of what is possible in modern pandemic management. At the same time, its unique ability to be recognized as a pseudo-purine by the viral enzyme is highly valued by global biotechnology firms. In short, our product serves as a dependable “precision-inhibitor” for companies focusing on both seasonal influenza and sustainable healthcare infrastructure.
Recently, scientific interest has surged regarding the synergistic effects of Favipiravir when combined with other nucleoside analogues. Because of this, Zyntex offers specialized analytical documentation to provide safer and more convenient validation in high-containment laboratory environments. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances chemical potency with rigorous logistical safety. To conclude, our commitment to chemical excellence ensures that your manufacturing processes—whether in fine chemistry or clinical research—achieve the highest levels of purity and yield.
Key Industrial Applications
This high-performance antiviral agent is specifically vital in the following four sectors:
🔬 Virological R&D
A potent agent for studying RdRp inhibition across viral families; thus enabling the production of high-value replication data.
💊 Pharma Development
Key API for oral broad-spectrum formulations; consequently vital for developing stable anti-influenza medications.
🧬 Genetic Mutagenesis
Used to study error-prone viral replication; undoubtedly essential for identifying viral evolutionary bottlenecks.
🧪 Analytical Profiling
Used as a reference standard in HPLC/Mass Spec; specifically helping researchers monitor drug concentration in metabolic studies.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Favipiravir (T-705) |
| Assay / Purity | Min. 99.0% |
| Molecular Formula | C5H4FN3O2 |
| CAS Number | 259793-96-9 |
⚠️ Safety Warning: Favipiravir has potential teratogenic and embryotoxic risks. Therefore, it must be handled under strict laboratory protocols by trained personnel using appropriate PPE. Avoid ingestion and skin contact. Store at room temperature or 4°C (as specified by batch) in a tightly sealed container, protected from light and moisture.
Safety and Regulatory Data
For comprehensive toxicological profiles, material safety data sheets (MSDS), and physical property validation, please refer to the official PubChem entry: Chemical Safety Data – Favipiravir (259793-96-9)
